Marina Ripamonti

552 total citations
18 papers, 467 citations indexed

About

Marina Ripamonti is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Marina Ripamonti has authored 18 papers receiving a total of 467 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Radiology, Nuclear Medicine and Imaging and 7 papers in Oncology. Recurrent topics in Marina Ripamonti's work include Monoclonal and Polyclonal Antibodies Research (8 papers), Cancer therapeutics and mechanisms (6 papers) and Toxin Mechanisms and Immunotoxins (4 papers). Marina Ripamonti is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (8 papers), Cancer therapeutics and mechanisms (6 papers) and Toxin Mechanisms and Immunotoxins (4 papers). Marina Ripamonti collaborates with scholars based in Italy, Spain and United Kingdom. Marina Ripamonti's co-authors include Maria Grandi, Silvana Canevari, M. Farao, F. Spreafico, Rosaria Orlandi, Leonard W. Seymour, Karel Ulbrich, Maria I. Colnaghi, Antonino Suarato and Jean Waikedre and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Journal of Controlled Release and British Journal of Cancer.

In The Last Decade

Marina Ripamonti

18 papers receiving 451 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marina Ripamonti Italy	11	237	112	105	104	92	18	467
Jill E. Porter United States	6	298 1.3×	171 1.5×	95 0.9×	76 0.7×	86 0.9×	7	653
D. Deprez-De Campeneere Belgium	8	289 1.2×	98 0.9×	218 2.1×	84 0.8×	119 1.3×	9	609
Ryan Dorton United States	12	315 1.3×	137 1.2×	219 2.1×	159 1.5×	130 1.4×	18	671
Ida H. van der Meulen‐Muileman Netherlands	14	291 1.2×	66 0.6×	110 1.0×	57 0.5×	37 0.4×	21	460
Isabella C. Hume United Kingdom	9	319 1.3×	147 1.3×	189 1.8×	168 1.6×	340 3.7×	9	730
Jinbiao Zhan China	13	258 1.1×	140 1.3×	170 1.6×	24 0.2×	46 0.5×	29	541
M. Szekerke Hungary	17	420 1.8×	166 1.5×	59 0.6×	131 1.3×	143 1.6×	42	639
R.F. Sherwood United Kingdom	10	341 1.4×	264 2.4×	139 1.3×	95 0.9×	47 0.5×	12	527
M. Farao Italy	7	236 1.0×	45 0.4×	128 1.2×	72 0.7×	166 1.8×	9	399
Paul J. Kleindl United States	14	378 1.6×	111 1.0×	214 2.0×	207 2.0×	105 1.1×	19	697

Countries citing papers authored by Marina Ripamonti

Since Specialization

Citations

This map shows the geographic impact of Marina Ripamonti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marina Ripamonti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marina Ripamonti more than expected).

Fields of papers citing papers by Marina Ripamonti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marina Ripamonti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marina Ripamonti. The network helps show where Marina Ripamonti may publish in the future.

Co-authorship network of co-authors of Marina Ripamonti

This figure shows the co-authorship network connecting the top 25 collaborators of Marina Ripamonti. A scholar is included among the top collaborators of Marina Ripamonti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marina Ripamonti. Marina Ripamonti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Geroni, Cristina, Marina Ripamonti, Claudio Arrigoni, et al.. (2001). Pharmacological and toxicological aspects of 4-demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548): a novel antineoplastic agent.. PubMed. 61(5). 1983–90. 17 indexed citations

Marchini, Sergio, et al.. (2001). 4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548), a novel anticancer agent active against tumor cell lines with different resistance mechanisms.. PubMed. 61(5). 1991–5. 9 indexed citations

Ripamonti, Marina, et al.. (1996). Morpholinylanthracyclines: cytotoxicity and antitumor activity of differently modified derivatives. Investigational New Drugs. 14(2). 139–146. 7 indexed citations

D’Ambrosio, Michele, Antonio Guerriero, Francesco Pietra, et al.. (1996). The Active Centres of Agelastatin A, a Strongly Cytotoxic Alkaloid of the Coral Sea Axinellid Sponge Agelas dendromorpha, as Determined by Comparative Bioassays with Semisynthetic Derivatives. Helvetica Chimica Acta. 79(3). 727–735. 66 indexed citations

Marchini, Sergio, Odalys Gonzalez Paz, Marina Ripamonti, et al.. (1995). Sequence-specific DNA interactions by novel alkylating anthracycline derivatives.. PubMed. 10(8). 641–53. 11 indexed citations

Capolongo, Laura, Nadia Amboldi, Dario Ballinari, et al.. (1994). Reversal of Multidrug Resistance by New Dihydropyridines with Low Calcium Antagonist Activity. Acta Oncologica. 33(7). 787–791. 3 indexed citations

Duncan, Ruth, Leonard W. Seymour, Stephen R. Wedge, et al.. (1992). Preclinical evaluation of polymer-bound doxorubicin. Journal of Controlled Release. 19(1-3). 331–346. 158 indexed citations

Ripamonti, Marina, Gabriella Pezzoni, Enrico Pesenti, et al.. (1992). In vivo anti-tumour activity of FCE 23762, a methoxymorpholinyl derivative of doxorubicin active on doxorubicin-resistant tumour cells. British Journal of Cancer. 65(5). 703–707. 44 indexed citations

Gadina, Massimo, S. Canevari, Marina Ripamonti, Massimo A. Mariani, & M. I. Colnaghi. (1991). Preclinical pharmacokinetics and localization studies of the radioiodinated anti-ovarian carcinoma MAb MOv18. International Journal of Radiation Applications and Instrumentation Part B Nuclear Medicine and Biology. 18(4). 403–408. 12 indexed citations

10.

Seymour, Leonard W., Karel Ulbrich, F. Spreafico, et al.. (1991). Preclinical evaluation of polymer-bound doxorubicin. European Journal of Cancer and Clinical Oncology. 27. S52–S52. 4 indexed citations

11.

Orlandi, Rosaria, et al.. (1989). The Aspergillus toxin restrictocin is a suitable cytotoxic agent for generation of immunoconjugates with monoclonal antibodies directed against human carcinoma cells. European Journal of Biochemistry. 178(3). 795–802. 34 indexed citations

12.

Ripamonti, Marina, Silvana Canevari, G.L. Buraggi, et al.. (1988). Monoclonal anti-CEA Antibody: Factors Affecting Localization in a Preclinical Study. The International Journal of Biological Markers. 3(4). 249–258. 2 indexed citations

13.

Orlandi, Rosaria, et al.. (1988). Immunoconjugate generation between the ribosome inactivating protein restrictocin and an anti-human breast carcinoma MAB. Cancer Immunology Immunotherapy. 26(2). 114–20. 28 indexed citations

14.

Colnaghi, M. I., S. Canevari, Rosanna Fontanelli, et al.. (1987). Monoclonal antibodies perspectives for tumor therapy. 137–146. 1 indexed citations

15.

Ripamonti, Marina, Silvana Canevari, Sylvie M�nard, et al.. (1987). Human carcinoma cell lines xenografted in athymic mice: biological and antigenic characteristics of an intraabdominal model. Cancer Immunology Immunotherapy. 24(1). 13–8. 17 indexed citations

16.

Orlandi, Rosaria, Silvana Canevari, Flavio Leoni, et al.. (1986). Change in Binding Reactivity of an Anti-Tumor Monoclonal Antibody After the Introduction of 2-Pyridyl Disulphide Groups. Hybridoma. 5(1). 1–8. 8 indexed citations

17.

Leoni, Flavio, Silvia Miotti, Silvana Canevari, et al.. (1986). Carbohydrate Epitope Defined by an Antitumor Monoclonal Antibody Detected on Glycoproteins and a Glycolipid by Immunoblotting. Hybridoma. 5(4). 289–296. 14 indexed citations

18.

Canevari, Silvana, Rosaria Orlandi, Marina Ripamonti, et al.. (1985). Ricin A Chain Conjugated With Monoclonal Antibodies Selectively Killing Human Carcinoma Cells In Vitro2. JNCI Journal of the National Cancer Institute. 75(5). 831–839. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact